FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Warner Chilcott Jevantique Recall

Jevantique (norethindrone acetate and ethinyl estradiol) tablets

Warner Chilcott Company LLC · Fajardo, PR

Risk level
Class III
Reported by FDA
May 8, 2013
Recall ID
D-304-2013
Check your lot numberHow we source this data

Summary

Warner Chilcott recalled Jevantique starting Feb 15, 2013. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-304-2013 on May 8, 2013. Reason: Chemical contamination: Firm's inspection discovered the presence of 2-phenylphenol in the product due to migration from the cardboard cartons in which the product is packaged. Status: Terminated.

Why it was recalled

Chemical contamination: Firm's inspection discovered the presence of 2-phenylphenol in the product due to migration from the cardboard cartons in which the product is packaged.

Product description

Jevantique (norethindrone acetate and ethinyl estradiol) tablets; 1.0 mg/5.0 mcg, 90 count bottle (NDC# 52544-237-19), Rx only, Manufactured by Warner Chilcott Company, LLC, Fajardo, PR 00738, Distributed by Watson Pharma, Inc. Corona, CA 92880.

Lot numbers, UPCs & expiration codes

Lot # 507694A; exp 02/13 Lot # 510041C; exp 05/13

Where it was sold

US Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-304-2013
Classification
Class III
Status
Terminated
Recall initiated
Feb 15, 2013
FDA report date
May 8, 2013
Quantity
17,136 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Warner Chilcott Company LLC

Original FDA data

Every field from FDA enforcement report D-304-2013, exactly as published.

Show all FDA fields
City
Fajardo
State
PR
Status
Terminated
Country
United States
Event ID
64459
Address
Road 195, Km 1.1
Address (line 2)
Union Street
Code information
Lot # 507694A; exp 02/13 Lot # 510041C; exp 05/13
Postal code
00738
Report date
May 8, 2013
Product type
Drugs
Recall number
D-304-2013
Classification
Class III
Recalling firm
Warner Chilcott Company LLC
Product quantity
17,136 bottles
Termination date
Jun 9, 2014
Reason for recall
Chemical contamination: Firm's inspection discovered the presence of 2-phenylphenol in the product due to migration from the cardboard cartons in which the product is packaged.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Jevantique (norethindrone acetate and ethinyl estradiol) tablets; 1.0 mg/5.0 mcg, 90 count bottle (NDC# 52544-237-19), Rx only, Manufactured by Warner Chilcott Company, LLC, Fajardo, PR 00738, Distributed by Watson Pharma, Inc. Corona, CA 92880.
Distribution pattern
US Nationwide and Puerto Rico
Recall initiation date
Feb 15, 2013
Initial firm notification
Letter
Center classification date
Apr 30, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-304-2013, published May 8, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls